Altered gene expression levels of matrix metalloproteinases and their inhibitors in periodontitis-affected gingival tissue

Journal of Periodontology

Volumn 79, Issue 1, 2008, Pages 166-173

  Kubota, Takehiko ^a   Itagaki, Manami ^a   Hoshino, Chika ^a   Nagata, Masaki ^a   Morozumi, Toshiya ^a   Kobayashi, Tetsuo ^a,b   Takagi, Ritsuo ^a   Yoshie, Hiromasa ^a  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^b NIIGATA UNIVERSITY MEDICAL AND DENTAL HOSPITAL   (Japan)

Author keywords

Matrix metalloproteinases; Periodontitis; Tissue inhibitor of matrix metalloproteinase

Indexed keywords

ACTIN; COLLAGENASE 3; GELATINASE B; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE; MMP1 PROTEIN, HUMAN; MMP13 PROTEIN, HUMAN; MMP3 PROTEIN, HUMAN; STROMELYSIN; TIMP3 PROTEIN, HUMAN; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TISSUE INHIBITOR OF METALLOPROTEINASE 3; TISSUE INHIBITOR OF METALLOPROTEINASE 4; TISSUE INHIBITOR OF METALLOPROTEINASE-4; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; CHRONIC DISEASE; COMPARATIVE STUDY; ENZYMOLOGY; FEMALE; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; GINGIVA; GINGIVITIS; HUMAN; MALE; PERIODONTITIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

ACTINS; ADOLESCENT; ADULT; CHRONIC DISEASE; FEMALE; GENE EXPRESSION REGULATION; GINGIVA; GINGIVITIS; HUMANS; MALE; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 13; MATRIX METALLOPROTEINASE 3; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASES; PERIODONTITIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TISSUE INHIBITOR OF METALLOPROTEINASE-3; TISSUE INHIBITOR OF METALLOPROTEINASES; TRANSCRIPTION, GENETIC; UP-REGULATION;

EID: 38549161744     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2008.070159     Document Type: Article

References (38)

1. Birkedal-Hansen H. Role of matrix metalloproteinases in human periodontal diseases. J Periodontol 1993;64: 474-484.
2. Reynolds JJ, Meikle MC. Mechanisms of connective tissue matrix destruction in periodontitis. Periodontol 2000 1997;14:144-157.
3. Kinane DF. Regulators of tissue destruction and homeostasis as diagnostic aids in periodontology. Periodontol 2000 2000;24:215-225.
4. Verstappen J, den Hoff JW. Tissue inhibitors of metalloproteinases (TlMPs): Their biological functions and involvement in oral disease. J Dent Res 2006;85:1074-1084.
5. Brew K, Dinakarpandian D, Nagase H. Tissue inhibitors of metalloproteinases: Evolution, structure and function. Biochim Biophys Acta 2000;1477:267-283.
6. Kantarci A, Hasturk H, Van Dyke TE. Host-mediated resolution of inflammation in periodontal diseases. Periodontol 2000 2006;40:144-163.
7. Kubota T, Nomura T, Takahashi T, Hara K. Expression of mRNA for matrix metalloproteinases and tissue inhibitors of metalloproteinases in periodontitis-affected human gingival tissue. Arch Oral Biol 1996;41:253-262.
8. Kubota T, Matsuki Y, Nomura T, Hara K. In situ hybridization study on tissue inhibitors of metalloproteinases (TIMPs) mRNA-expressing cells in human inflamed gingival tissue. J Periodontal Res 1997;32:467-472.
9. Ejeil AL, Igondjo-Tchen S, Ghomrasseni S, Pellat B, Godeau G, Gogly B. Expression of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in healthy and diseased human gingiva. J Periodontol 2003;74:188-195.
10. Kiili M, Cox SW, Chen HW, et al. Collagenase-2 (MMP-8) and collagenase-3 (MMP-13) in adult periodontitis: Molecular forms and levels in gingival crevicular fluid and immunolocalisation in gingival tissue. J Clin Periodontol 2002;29:224-232.
11. Smith PC, Munoz VC, Collados L, Oyarzun AD. In situ detection of matrix metalloproteinase-9 (MMP-9) in gingival epithelium in human periodontal disease. J Periodontal Res 2004;39:87-92.
12. Hernandez M, Valenzuela MA, Lopez-Otin C, et al. Matrix metalloproteinase-13 is highly expressed in destructive periodontal disease activity. J Periodontol 2006;77:1863-1870.
13. Higashikata T, Yamagishi M, Higashi T, et al. Altered expression balance of matrix metalloproteinases and their inhibitors in human carotid plaque disruption: Results of quantitative tissue analysis using real-time RT-PCR method. Atherosclerosis 2006;185:165-172.
14. Heid CA, Stevens J, Livak KJ, Williams PM. Real time quantitative PCR. Genome Res 1996;6:986-994.
15. Monney L, Sabatos CA, Gaglia JL, et al. Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease. Nature 2002;415:536-541.
16. Nagase H. Activation mechanisms of matrix metalloproteinases. Biol Chem 1997;378:151-160.
17. Henderson N, Markwick LJ, Elshaw SR, Freyer AM, Knox AJ, Johnson SR. Collagen I and thrombin activate MMP-2 by MMP-14-dependent and -independent pathways: Implications for airway smooth muscle migration. Am J Physiol Lung Cell Mol Physiol 2007;292:L1030-1038.
18. Morrison CJ, Overall CM. TIMP-independence of matrix metalloproteinase (MMP)-2 activation by membrane type 2 (MT2)-MMP is determined by contributions of both the MT2-MMP catalytic and hemopexin domains J Biol Chem 2006;281:26528-26539.
19. Kim DM, Ramoni MF, Nevins M, Fiorellini JP. The gene expression profile in refractory periodontitis patients. J Periodontol 2006;77:1043-1050.
20. Nomura T, Takahashi T, Hara K. Expression of TIMP-1, TIMP-2 and collagenase mRNA in periodontitis-affected human gingival tissue. J Periodontal Res 1993;28:354-362.
21. Séguier S, Gogly B, Bodineau A, Godeau G, Brousse N. Is collagen breakdown during periodontitis linked to inflammatory cells and expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gingival tissue? J Periodontol 2001;72:1398-1406.
22. Westerlund U, Ingman T, Lukinmaa PL, et al. Human neutrophil gelatinase and associated lipocalin in adult and localized juvenile periodontitis. J Dent Res 1996;75:1553-1563.
23. Bainton DF, Ullyot JL, Farquhar MG. The development of neutrophilic polymorphonuclear leukocytes in human bone marrow. J Exp Med 1971;134:907-934.
24. Kinane DF, Darby IB, Said S, et al. Changes in gingival crevicular fluid matrix metalloproteinase-8 levels during periodontal treatment and maintenance. J Periodontal Res 2003;38:400-404.
25. Leeman MF, McKay JA, Murray GI. Matrix metalloproteinase 13 activity is associated with poor prognosis in colorectal cancer. J Clin Pathol 2002;55:758-762.
26. Tardif G, Reboul P, Pelletier JP, Martel-Pelletier J. Ten years in the life of an enzyme: The story of the human MMP-13 (collagenase-3). Mod Rheumatol 2004;14:197-204.
27. Spinale FG. Matrix metalloproteinases: Regulation and dysregulation in the failing heart. Circ Res 2002;90:520-530.
28. Stetler-Stevenson WG, Liotta LA, Kleiner DE Jr. Extracellular matrix 6: Role of matrix metalloproteinases in tumor invasion and metastasis. FASEB J 1993;7:1434-1441.
29. Engelmyer E, van Goor H, Edwards DR, Diamond JR. Differential mRNA expression of renal cortical tissue inhibitor of metalloproteinase-1, -2, and -3 in experimental hydronephrosis. J Am Soc Nephrol 1995;5:1675-1683.
30. Black RA. TIMP-3 checks inflammation. Nat Genet 2004;36:934-935.
31. Maeso G, Bravo M, Bascones A. Levels of metalloproteinase-2 and -9 and tissue inhibitor of matrix metalloproteinase-1 in gingival crevicular fluid of patients with periodontitis, gingivitis and healthy gingiva. Quintessence Int 2007;38:247-252.
32. Schulze CJ, Wang W, Suarez-Pinzon WL, Sawicka J, Sawicki G, Schulz R. Imbalance between tissue inhibitor of metalloproteinase-4 and matrix metalloproteinases during acute myocardial [correction of myoctardial] ischemia-reperfusion injury. Circulation 2003;107:2487-2492.
33. Ramamurthy NS, Greenwald RA, Celiker MY, Shi EY. Experimental arthritis in rats induces biomarkers of periodontitis which are ameliorated by gene therapy with tissue inhibitor of matrix metalloproteinases. J Periodontol 2005;76:229-233.
34. Golub LM, Ryan ME, Williams RC. Modulation of the host response in the treatment of periodontitis. Dent Today 1998;17:102-106, 108-109.
35. Itagaki M, Kubota T, Tai H, Shimada Y, Morozumi T, Yamazaki K. Matrix metalloproteinase-1 and -3 gene promoter polymorphisms in Japanese patients with periodontitis. J Clin Periodontol 2004;31:764-769.
36. Woessner JF Jr. Quantification of matrix metalloproteinases in tissue samples. Methods Enzymol 1995;248:510-528.
37. Garlet GP, Martins W Jr., Fonseca BAL, Ferreira BR, Silva JS. Matrix metalloproteinases, their physiological inhibitors and osteoclast factors are differently regulated by the cytokine profile in human periodontal disease. J Clin Periodontol 2004-31:671-679.
38. Emingil G, Tevahartiala T, Mantyla P, Määttä M, Sorsa T, Atilla G. Gingival crevicular fluid matrix metalloproteinase (MMP)-7, extracellular MMP inducer, and tissue inhibitor of MMP-1 levels in periodontal disease. J Periodontol 2006;77:2040-2050.